GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (NAS:SMLR) » Definitions » Equity-to-Asset

Semler Scientific (Semler Scientific) Equity-to-Asset : 0.92 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Semler Scientific Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Semler Scientific's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $71.80 Mil. Semler Scientific's Total Assets for the quarter that ended in Dec. 2023 was $78.07 Mil. Therefore, Semler Scientific's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.92.

The historical rank and industry rank for Semler Scientific's Equity-to-Asset or its related term are showing as below:

SMLR' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.95   Med: 0.63   Max: 0.92
Current: 0.92

During the past 13 years, the highest Equity to Asset Ratio of Semler Scientific was 0.92. The lowest was -0.95. And the median was 0.63.

SMLR's Equity-to-Asset is ranked better than
94.48% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs SMLR: 0.92

Semler Scientific Equity-to-Asset Historical Data

The historical data trend for Semler Scientific's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific Equity-to-Asset Chart

Semler Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.86 0.90 0.89 0.92

Semler Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.87 0.87 0.89 0.92

Competitive Comparison of Semler Scientific's Equity-to-Asset

For the Medical Devices subindustry, Semler Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Semler Scientific's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Semler Scientific's Equity-to-Asset falls into.



Semler Scientific Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Semler Scientific's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=71.795/78.065
=0.92

Semler Scientific's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=71.795/78.065
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Semler Scientific  (NAS:SMLR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Semler Scientific Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Semler Scientific's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Semler Scientific (Semler Scientific) Business Description

Traded in Other Exchanges
Address
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Executives
Eric Semler director 4625 FIELDSTON ROAD, BRONX NY 10471
Renae Cormier officer: Chief Financial Officer C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVE, SUITE 2344, SANTA CLARA CA 95051
Douglas Murphy-chutorian director, 10 percent owner, officer: Chief Executive Officer C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Wayne T Pan director 2330 NW EVERETT STREET, PORTLAND OR 97210
William H.c. Chang & Diana Shon Chang Ttee Chang Family Trust U/a Dtd 10/23/2006 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN CT., SAN JOSE CA 95112
Chang 2020 Delaware Lp 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, SUITE 2344, SANTA CLARA CA 95051
Arthur N Leibowitz director C/O I-TRAX INC, ONE LOGAN SQUARE STE 2615, PHILADELPHIA PA 19103
Chang 2020 Gp Llc 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2340-2348 WALSH AVENUE, STE. 2344, SANTA CLARA CA 95051
Cindy Moon director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SAN JOSE CA 95112
Daniel S Messina director C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, STE. 110, SAN JOSE Z4 95112
Daniel E Conger officer: Vice President, Finance C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
William H Chang 10 percent owner C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Diana Shon Chang 10 percent owner 1301 SHOREWAY RD., SUITE 150, BELMONT CA 94002
Andrew B. Weinstein officer: Senior VP, Finance and Acct. C/O SEMLER SCIENTIFIC, INC., 911 BERN COURT, SUITE 110, SAN JOSE CA 95112
Herbert J Semler director, 10 percent owner C/O SEMLER SCIENTIFIC, INC., 2330 NW EVERETT ST., PORTLAND OR 97210